OnExamination MRCP Part 1 (Updated Feb 2023)
Pass your MRCP Part 1 exam with confidence
Our MRCP Part 1 revision resource is fully aligned with the Royal College of Physicians curriculum, giving you the closest revision experience possible to the exam.
Revise with quality questions and detailed explanations
Demo Question A 39-year-old sailor has had repeated visits to his GP for heartburn and dyspepsia. He had been an irregular visitor and his treatments had been discontinuous in the past.
This time, after an acute episode of dyspepsia and abdominal pain, he underwent an upper GI endoscopy which showed Barret’s esophagus. Histopathology showed very low-grade dysplasia. What is the best next line of management? Endoscopic ablation therapy A trial of PPI therapy Endoscopic mucosal resection Lower esophageal resection Only observation Key learning points Barret’s esophagus is treated with PPI as first line therapy. Explanation Barret’s oesophagus occurs due to gastro-oesophagal reflux disease. The initial therapy for this condition is PPI-based. Usually, once-daily dosing of PPI is preferred. Observation only is not a preferred strategy. Barret’s oesophagus is a premalignant condition. Hence, quick intervention is needed. The three remaining therapies are used in the NICE pathways in patients with moderate to severe grade dysplasia. Also, if there is inadequate response to PPI therapy, then these modalities of treatment may be tried. They are also used for recurrent disease.
